Sensus Healthcare, Inc. Cash and Restricted Cash
Sensus Healthcare, Inc. (SRTS) had Cash and Restricted Cash of $15.19 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.19M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.33M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22.08M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.45M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $15.19M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $18.33M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $22.08M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $24.45M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $22.16M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $19.07M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $22.06M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $22.56M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $18.97M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $14.73M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $23.15M 10-K · filed 2026-03-04 |
| 2023-09-30 | $20.49M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $20.05M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $19.34M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $25.52M 10-K · filed 2025-03-05 |
| 2022-09-30 | $37.58M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $33.70M 10-Q · filed 2023-08-11 |
| 2022-03-31 | $32.83M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $14.52M 10-K · filed 2024-03-15 |
| 2021-09-30 | $16.39M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $15.20M 10-Q · filed 2022-08-12 |
| 2021-03-31 | $13.65M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $14.91M 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |